NICU Antibiotics and Outcomes (NANO) Follow-up Study

Starting soon · Phase 3 · Has a placebo group

Conditions studied: Premature Birth, Antibiotics, Neurodevelopment

In brief

The NANO follow-up study is designed to determine whether a simple, cost-effective intervention- withholding antibiotics at birth- reduces clinically relevant outcomes such as behavioral and neurological impairment at 2 years of age. This study will be the largest study evaluating the effects of early antibiotics in children with comprehensive measures of neurodevelopment linked to genomic variants and microbiota interactions.

Key facts

Study ID
NCT05977400
Run by
Sharp HealthCare
People needed
802
Starts
2024-04-01
Expected to finish
2029-03-01
Last updated by the study team
2023-08-04

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.